NCT00514813View on ClinicalTrials.gov

Dynepo Long-Term Safety Study

PHASE4TerminatedINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

June 6, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

AnemiaKidney Failure, Chronic

Interventions

DRUG

Dynepo

Subcutaneous injection either BIW, QW, Q2W or Q4W based on what is appropriate for the subject

Trial Locations (1)

Unknown

Heilig Hartziekenhuis Department of Nephrology, Lier

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Shire

INDUSTRY

NCT00514813 - Dynepo Long-Term Safety Study | Biotech Hunter | Biotech Hunter